Rhoifolin potentiates the anti-cancer activity of doxorubicin in MDA-MB-231 triple-negative breast cancer cells


	Effect of Dox, rhoifolin, and their combinations on MDA-MB-231 cell migration. Each experiment was conducted in triplicate. Data are presented as mean ± SD. p < 0.05, p < 0.01, p < 0.001, **p < 0.0001.

Part of: Al-Radaideh AS, Abbas MA, Al-Kabariti AY, Alqaraleh M, Madi R, Obeidat R (2025) Rhoifolin potentiates the anti-cancer activity of doxorubicin in MDA-MB-231 triple-negative breast cancer cells. Pharmacia 72: 1-9. https://doi.org/10.3897/pharmacia.72.e148600